GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Owner Earnings per Share (TTM)

Biotage AB (Biotage AB) Owner Earnings per Share (TTM) : 0.37 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Biotage AB's Owner Earnings per Share (TTM) ended in Mar. 2024 was $0.37. It's Price-to-Owner-Earnings ratio for today is 39.54.


The historical rank and industry rank for Biotage AB's Owner Earnings per Share (TTM) or its related term are showing as below:

BITGF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 14.02   Med: 42.66   Max: 77.95
Current: 39.28


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Biotage AB was 77.95. The lowest was 14.02. And the median was 42.66.


BITGF's Price-to-Owner-Earnings is ranked worse than
59.71% of 278 companies
in the Medical Devices & Instruments industry
Industry Median: 32.93 vs BITGF: 39.28

Biotage AB's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $0.04. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30. It's PE Ratio ratio for today is 49.09.

Biotage AB's EPS without NRI for the three months ended in Mar. 2024 was $0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30. It's PE Ratio without NRI ratio for today is 49.09.


Biotage AB Owner Earnings per Share (TTM) Historical Data

The historical data trend for Biotage AB's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Owner Earnings per Share (TTM) Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.38 0.44 0.39 0.29

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.29 0.26 0.29 0.40

Competitive Comparison of Biotage AB's Owner Earnings per Share (TTM)

For the Medical Instruments & Supplies subindustry, Biotage AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Biotage AB's Price-to-Owner-Earnings falls into.



Biotage AB Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Biotage AB's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 22.5
Depreciation, Depletion and Amortization 15.8
Change In Deferred Tax 0.0
5Y Average of Maintenance Capital Expenditure 6.6
Change In Working Capital -0.3
Shares Outstanding (Diluted Average) 80.1

1. Start with "Net Income" from income statement. Biotage AB's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was $22.5 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Biotage AB's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Mar. 2024 was $15.8 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Biotage AB's Change In Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $6.6 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Biotage AB's 5-Year Average Maintenance Capital Expenditure = $6.6 Mil

5. "Change In Working Capital" is from cashflow statement. Biotage AB's Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.3 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Biotage AB's Shares Outstanding (Diluted Average) for the months ended in Mar. 2024 was 80.064 Mil.

Biotage AB's Onwer Earnings Per Share for Mar. 2024 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 22.526 +15.818+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-6.5774949201007+-0.345)/80.064
=0.37

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=14.63/0.37
=39.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Biotage AB Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Biotage AB's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 10-25-2021

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 09-24-2020

Berenberg Bank is now covering Biotage AB (publ) (BIOT)

By PRNewswire PRNewswire 06-29-2021

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021

Change in number of shares and votes

By PRNewswire PRNewswire 12-30-2021

Biotage AB (publ) Interim report January - June 2021

By PRNewswire PRNewswire 07-16-2021

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021